# OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one blaKPC-2

**Authors:** Susu Wu, Yinyin Yang, Wanyao Xiang, Jin Zhang, Xinhua Luo, Mengqiao Xu, Dakang Hu, Haifang Zhang

PMC · DOI: 10.3389/fcimb.2026.1735799 · Frontiers in Cellular and Infection Microbiology · 2026-02-20

## TL;DR

This study explores how the absence of OmpK35/36 porins in Klebsiella pneumoniae affects resistance to certain antibiotics like carbapenems and ceftazidime-avibactam.

## Contribution

The study reveals that OmpK35/36 loss contributes to, but does not solely cause, antibiotic resistance in Klebsiella pneumoniae.

## Key findings

- OmpK35/36 absence increases resistance to β-lactams, especially when combined with blaKPC-2.
- OmpK36 plays a more significant role than OmpK35 in conferring resistance.
- Loss of OmpK35/36 is not sufficient alone to confer carbapenem resistance.

## Abstract

Investigate the genetic background of porin OmpK35/36 in Klebsiella pneumoniae and their influence on antimicrobial susceptibility, particularly carbapenems and ceftazidime-avibactam (CZA).

1407 K. pneumoniae genomes in GenBank were selected for analyzing outer membrane protein-related genes through BLAST method, including ompK35, ompK36, ompK26, ompK37, ompA, ompR, and carbapenemase genes, including blaKPC, blaVIM, blaIMP, blaNDM, blaOXA-48. Using MEGA 11.0, OmpK35/36 and ompK35/36 phylogenetic trees were built among serotypes K1 and K2 strains. Further, serotype K1 NTUH-K2044 and blaKPC-2 were used to construct mutants to elucidate impacts of OmpK35/36 on drug-resistance.

The rates of ompK35, ompK36, ompK26, ompK37, ompA, and ompR in K. pneumoniae strains were 97.5%, 99.3%, 99.5%, 99.4%, 99.9%, and 100.0% respectively. The sequence similarities of OmpK35/36 and ompK35/36 were both over 90.0%. K. pneumoniae strains with abnormal ompK35/36 presented higher rates of carbapenemase genes than those with normal ompK35/36. As to ΔompK36, the minimum inhibitory concentrations (MICs) of piperacillin, cefoxitin, cefazolin, cefuroxime, and imipenem increased to 4, 4, 4, 8, and 4 times respectively compared with those against NTUH-K2044; the MICs of piperacillin, cefoxitin, cefazolin, cefuroxime, imipenem, and meropenem increased to 8, 32, 32, 16, 8, and 8 times in ΔompK35/36 respectively. The deletions of ompK35/36, especially the double deletion, would greatly help NTUH-K2044+blaKPC-2 induce resistance to certain β-lactams. Further, the absence of ompK35/36 elevated the MIC of CZA against NTUH-K2044+blaKPC-2.

Highly conserved ompK35/36 are widely present in K. pneumoniae strains. The loss of OmpK35/36 confers increased resistance to certain β-lactams, with OmpK36 being dominant. Moreover, OmpK35/36 loss is a contributor but not a determinant in the formation of carbapenem-resistance under the absence of blaKPC-2, as well as in the formation of CZA-resistance with one blaKPC-2.

## Linked entities

- **Genes:** ompK35 (porin OmpK35) [NCBI Gene 69756156], ompK36 (porin OmpK36) [NCBI Gene 57503781], ompK26 (KdgM family porin OmpK26) [NCBI Gene 69753611], ompK37 (porin OmpK37) [NCBI Gene 69755205], ompa (olfactory marker protein a) [NCBI Gene 574006], ompR (regulatory component of sensory transduction system) [NCBI Gene 800287]
- **Proteins:** ompK35 (porin OmpK35), ompK36 (porin OmpK36)
- **Chemicals:** piperacillin (PubChem CID 43672), cefoxitin (PubChem CID 441199), cefazolin (PubChem CID 33255), cefuroxime (PubChem CID 5479529), imipenem (PubChem CID 104838), meropenem (PubChem CID 441130), ceftazidime-avibactam (PubChem CID 90643431)
- **Species:** Klebsiella pneumoniae (taxon 573)

## Full-text entities

- **Genes:** blaOXA-48 [NCBI Gene 15842812], bla KPC-2 [NCBI Gene 13923837]
- **Diseases:** OMP (MESH:C562589), endocarditis (MESH:D004696), lung abscess (MESH:D008169), sepsis (MESH:D018805), infections (MESH:D007239), endogenous endophthalmitis (MESH:D009877), pyogenic liver abscess (MESH:D046290), CRKP (MESH:D011014)
- **Chemicals:** imipenem (MESH:D015378), apramycin (MESH:C011666), lipopolysaccharide (MESH:D008070), sucrose (MESH:D013395), cefazolin (MESH:D002437), beta-lactam (MESH:D047090), cefoperazone (MESH:D002438), CP003200.1 (-), cefotaxime (MESH:D002439), cefuroxime (MESH:D002444), CZA (MESH:C000595613), aztreonam (MESH:D001398), glycerol (MESH:D005990), sulbactam (MESH:D013407), cephalosporins (MESH:D002511), quinolones (MESH:D015363), rifampicin (MESH:D012293), carbapenem (MESH:D015780), ceftazidime (MESH:D002442), cefepime (MESH:D000077723), meropenem (MESH:D000077731), taniborbactam (MESH:C000707821), cefoxitin (MESH:D002440), NaCl (MESH:D012965), aminoglycosides (MESH:D000617), piperacillin (MESH:D010878), polysaccharide (MESH:D011134), agar (MESH:D000362)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573]
- **Cell lines:** NTUH — Homo sapiens (Human), Familial amyloid neuropathy, Induced pluripotent stem cell (CVCL_RP90), DH5alpha — Drosophila hydei (Fruit fly), Spontaneously immortalized cell line (CVCL_Z531), HS11286 — Homo sapiens (Human), Cystic fibrosis, Transformed cell line (CVCL_V230), K2044 — Homo sapiens (Human), Transformed cell line (CVCL_K806)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963322/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963322/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963322/full.md

---
Source: https://tomesphere.com/paper/PMC12963322